NL-OMON26294
Not yet recruiting
Not Applicable
PhenotYpe Research for ALS ModIfyer Discovery.
niversity Medical Center Utrecht, the NetherlandsVesalius Research Center, VIB, Leuven, BelgiumUniversity Hospital Jena, Germany0 sites600 target enrollmentTBD
ConditionsALS, MND, amyotrophic lateral sclerosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- ALS, MND, amyotrophic lateral sclerosis
- Sponsor
- niversity Medical Center Utrecht, the NetherlandsVesalius Research Center, VIB, Leuven, BelgiumUniversity Hospital Jena, Germany
- Enrollment
- 600
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with ALS.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Phenotype, Genotype and Biomarkers 2Amyotrophic Lateral SclerosisHereditary Spastic ParaplegiaPrimary Lateral SclerosisProgressive Muscular AtrophyFrontotemporal DementiaNCT04875416University of Miami217
Unknown
Not Applicable
Phenotype, Genotype & Biomarkers in ALS and Related DisordersAmyotrophic Lateral SclerosisFrontotemporal DementiaPrimary Lateral SclerosisHereditary Spastic ParaplegiaProgressive Muscular AtrophyMultisystem ProteinopathyNCT02327845University of Miami700
Completed
Not Applicable
The study of ALS biomarker based on molecular dynamics of oxidative stress regulatory factorAmyotrophic lateral sclerosis Parkinson's disease Multiple sclerosis Healthy individualsJPRN-UMIN000013245Faculty of Medicine, Kitasato University60
Completed
Not Applicable
Muscular Biomarkers in Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT02670226University Hospital, Tours37
Recruiting
Not Applicable
Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis DiagnosisAmyotrophic Lateral SclerosisNCT06083584Centre Hospitalier Universitaire de Nīmes192